Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MILANOS
2024-512757-24-00Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in septic shock comparing Standard of care with Landiolol treatment (2 arms). Started Jul 2022; status: completed.
02
Drugs
landiolol
03
Conditions
septic shock
Beyond the preview
Go deeper on 2024-512757-24-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-512757-24-00.